OBI Pharma, Inc. announced the change of internal audit officer. Name, title, and resume of the previous position holder: Neo Chien/Director /Internal audit director, OBI Pharma Inc. Name, title, and resume of the new position holder: Hanna Hsu/Supervisor /Internal audit supervisor, OBI Pharma Inc. Reason for the change: Position adjustment. Effective date: November 6, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59.8 TWD | -0.50% | -1.32% | -13.83% |
1st Jan change | Capi. | |
---|---|---|
-13.83% | 424M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+44.36% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- 4174 Stock
- News OBI Pharma, Inc.
- OBI Pharma, Inc. Announces Internal Audit Officer Changes